Form 8-K · Current Report · Filed 2025-04-23
Philip Morris International Reports Strong Q1 2025 Results with EPS Growth and Raised Guidance
Philip Morris International Inc. reported strong financial results for Q1 2025, with reported diluted EPS growing by 24.6% to $1.72 and adjusted diluted EPS increasing by 12.7% to $1.69. The company experienced robust growth in its smoke-free business, particularly in IQOS and nicotine pouches, driving net revenue growth of 10.2% organically. Despite the global economic volatility, PMI raised its 2025 full-year adjusted diluted EPS forecast for currency only to a range of $7.36 to $7.49, anticipating double-digit growth in adjusted diluted EPS. The strong performance was supported by volume growth, favorable pricing variances, and increased market shares across various regions.
- Filer
- Philip Morris International Inc. PM · NYSE
- Filed
- Accession
- 0001413329-25-000091
- CIK
- 0001413329
- Signal
- High impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$164.11
Next session
+3.6%
Since filing
+16.3%
Latest close
$190.82
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from PM reporting the same item, with the next session's move:
Exhibits (2)
About Philip Morris International Inc.
Philip Morris International Inc. is a leading global tobacco company primarily engaged in the manufacture and sale of cigarettes and other nicotine-containing products. Known for owning some of the world's best-selling cigarette brands like Marlboro, Philip Morris International plays a significant role in the consumer goods sector. The company's strategic focus includes developing smoke-free alternatives such as heated tobacco systems and e-cigarettes, addressing shifting consumer preferences and regulatory landscapes. Headquartered in New York City, Philip Morris operates in over 180 countries, showcasing a robust international presence. The firm is noteworthy for its commitment to transforming public health narratives within the tobacco industry by advocating for reduced-risk products. As part of its market significance, Philip Morris International drives innovation in tobacco products, influencing regulatory frameworks and competitive dynamics in the global market.
Never miss another PM filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.